Newsfeeds Archive - Page 27 of 167

1 minute read

2seventy bio Announces Expanded Translational Collaboration With Regeneron To Develop New Cell Therapy-Based Combinations Dor Solid Tumors; Regeneron To Invest $20M In 2seventy Equity

January 6, 10:12 AM

Collaboration Leverages 2seventy's Platform for T Cell Therapy Research and Development with Regeneron Antibodies and Bispecifics to Explore Multiplex Combination Approaches Regeneron Investing $20

REGN

1 minute read

General

‘Smartphone maker Xiaomi to take on Tesla with its first EV’ -SCMP

By Bill Haddad

January 6, 8:35 AM

https://www.scmp.com/business/china-business/article/3205892/smartphone-maker-xiaomi-has-tesla-its-sights-it-reportedly-plans-debut-first-car-model-year-end?module=live&pgtype=homepage

TSLA

1 minute read

Phillips 66 Reaches Agreement To Acquire Publicly Held Common Units Of DCP Midstream, LP For $41.75/Unit; Will Increase Interest To 86.8%

By Bill Haddad

January 6, 8:31 AM

Phillips 66 (NYSE:PSX) and DCP Midstream, LP ("DCP Midstream") (NYSE:DCP) announced today that they have entered into a definitive agreement pursuant to which Phillips 66 will acquire all of the publicly held

DCP

1 minute read

Precision BioSciences Receives Favorable Type C Feedback From FDA On Company’s Chemistry, Manufacturing And Controls Strategies For Late-Stage Development Of Azercabtagene Zapreleucel, Its Lead Allogeneic CAR T Clinical Candidate

By Bill Haddad

January 6, 8:02 AM

- FDA feedback signals the Company's CMC plans shared are in alignment with Agency requirements and expectations

DTIL

1 minute read

Spruce Biosciences And Kaken Pharmaceutical Announce Exclusive Licensing Agreement To Develop And Commercialize Tildacerfont For CAH In Japan; Spruce To Receive $15M Upfront Payment Plus Milestones And Royalies

By Bill Haddad

January 5, 5:01 PM

Partnership aims to accelerate global development and commercialization plans for tildacerfont to address worldwide unmet medical need in congenital adrenal hyperplasia (CAH) Deal advances strategy to partner

SPRB

1 minute read

General

D-Wave and Davidson Technologies Enter Multi-Year Reseller Agreement

By Bill Haddad

January 5, 10:14 AM

D-Wave Quantum Inc. (NYSE:QBTS), a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers; and Davidson Technologies, Inc., a technology

QBTS

1 minute read

General

Aditxt Forms Adimune, Inc. As A Wholly Owned Subsidiary With A Focus On Immune Modulation Therapies

By Bill Haddad

January 3, 10:08 AM

Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today

ADTX

1 minute read

Acadia Pharmaceuticals Highlights Publication Of NUPLAZID analysis In Drug Safety

By Bill Haddad

January 3, 10:06 AM

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) announced today that the journal Drug Safety published results from a retrospective analysis finding a lower mortality risk in patients with Parkinson's disease

ACAD

1 minute read

Legal
News

Google Alleges Indian Antitrust Body Copied Parts Of Eu Decision On Android Abuse, Seeks To Quash Indian Antitrust Ruling On Android Abuse, Says Probe Not Conducted Impartially

By Bill Haddad

January 3, 8:54 AM

-Reuters

GOOG

1 minute read

Great Elm Group Sells A Majority Interest In Forest Investments, Inc. To An Affiliate Of JPMorgan Chase & Co. For $18M In Cash

By Bill Haddad

January 3, 8:07 AM

Transaction Highlights GEG has sold 61% of its direct and indirect common equity of Forest to JPM for approximately $18 million in cash. Together with its purchase of 20% of the common

GEG